Feedback / Questions
EndoTAG-1 (paclitaxel liposomal) - SynCore Biotechnology
Company Presentation
(MediGene)
-
Sep 4, 2012 -
"PFS rate (16 wks) in combination therapy group 59.1%; mOS (41 wks) in combination therapy group up to 13.0 months, in subgroup (ECOG 0/1, first line) up to 17.8 months"
P2 data
•
Breast Cancer
http://www.larvolonline.com/tlg/ccdb/MedigeneCompanyPresentationAug012012.pdf
Sep 4, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
(IR7)